A case of cytophagic histiocytic panniculitis associated with exertional rhabdomyolysis.
An 18-year-old man who suffered from panniculitis involving the entire left lower limb after exertional rhabdomyolysis is reported. A high fever (>39 degrees C) and leukocytosis (>20,000/microL) persisted for 1 week, and his general status deteriorated rapidly into pre-disseminated intravascular coagulation, complicated by pleural effusion and prolonged clotting time. His condition was dramatically improved by steroid pulse therapy and he has remained in good health for the 20 months since discharge. Histologic examination of subcutaneous tissue from the swollen left lower limb revealed pleomorphic small, medium or large lymphocytes, macrophages and neutrophils infiltrating the edematous subcutaneous adipose tissue in a lobular panniculitis-like pattern. The majority of inflammatory cells were T lymphocytes, with equal proportions of CD4+ and CD8+ cells. As polymerase chain reaction did not show bands suggesting T cell receptor gamma gene rearrangement, the proliferation of T lymphocytes was considered to be polyclonal. The T lymphocytes also expressed Fas ligand, suggesting the involvement of Fas-mediated cytotoxicity. This case may represent a new category of cytophagic histiocytic panniculitis induced by exertional rhabdomyolysis.
Kanai
Y
Y
Department of Internal Medicine, Self Defense Force Hospital of Yokosuka, Kanagawa, Japan.
Iwaya
K
K
Kuroda
M
M
Harada
M
M
Hirata
F
F
Mukai
K
K
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016516:CD4-CD8 Ratio; D053222:Fas Ligand Protein; D006644:Histiocytes / Q000473:pathology; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism; D008775:Methylprednisolone / Q000008:administration & dosage; D010201:Panniculitis, Nodular Nonsuppurative / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D005082:Physical Exertion; D020551:Pulse Therapy, Drug; D012206:Rhabdomyolysis / Q000150:complications / Q000473:pathology*; D012867:Skin / Q000378:metabolism / Q000473:pathology; D013601:T-Lymphocytes / Q000378:metabolism / Q000473:pathology
D000900:Anti-Bacterial Agents; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D008775:Methylprednisolone